Journal Article Summary

The article investigates the effectiveness of two intranasal steroid sprays, mometasone furoate and fluticasone furoate, in treating persistent allergic rhinoconjunctivitis, which includes both nasal and eye allergy symptoms. This topic is important because allergic rhinoconjunctivitis affects many individuals, leading to discomfort and a reduced quality of life. While intranasal steroids are commonly recommended for managing these symptoms, there has been limited direct comparison between these two specific medications, making this study relevant for better treatment options.

In this study, 78 patients aged 12 to 59 with persistent allergic rhinoconjunctivitis were evaluated over eight weeks. Participants were randomly assigned to receive either mometasone furoate or fluticasone furoate, and their symptoms were assessed using daily diaries and questionnaires. The results showed that both medications significantly reduced nasal and ocular symptoms after one week, with improvements continuing over the two months. However, there was no significant difference in effectiveness between the two treatments, indicating that both are viable options for managing allergic rhinoconjunctivitis.

The study has some limitations, including a relatively small sample size and a high dropout rate, primarily due to noncompliance. Additionally, most participants had mild ocular symptoms, which may affect the generalizability of the findings. Patients should consult with their healthcare providers to discuss their specific symptoms and treatment options, as individual responses to these medications can vary. It is also important to consider that while both treatments improved quality of life, they may not completely restore it to normal levels.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Aneeza W. Hamizan, Husain Salina, Rahman Roslenda Abdul, Van Dort Dexter, Abdullah Asma, Gendeh Balwant S.. Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis. Allergy & Rhinology 2013. DOI: 10.2500/ar.2013.4.0065. PMID: 24498516. PMCID: PMC3911800.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]